NEWARK, Calif., March 2, 2020 /PRNewswire/ -- Protagonist Therapeutics, Inc. (Nasdaq:PTGX) will announce fourth quarter and year end 2019 financial results after the NASDAQ market closes on Tuesday, March 10, 2020. Protagonist management will host a year end update call at 4:30 p.m. EDT/

WOONSOCKET, R.I. and SAN JOSE, Calif., March 2, 2020 /PRNewswire/ -- CVS Kidney Care, a CVS Health (NYSE: CVS) company, and Satellite Healthcare today announced a strategic relationship to advance the care of patients with kidney disease. CVS Kidney Care and Satellite Healthcare will collaborate to provide comprehensive kidney care, and t

MARBLEHEAD, Mass., March 2, 2020 /PRNewswire/ -- Americans are worried about the impact of the coronavirus on our health care system and the U.S. economy. At least 1 in 2 Americans believe the coronavirus poses a serious risk to the U.S. economy (52%) and that there is a serious risk that coronavirus could overwhelm our health care system (53%), according to a new s

FRANKLIN LAKES, N.J., March 2, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Barclays Global Healthcare Conference on Wednesday, March 11, 2020, at 10:45 a.m. ET.A live webcast of BD's presentati

WASHINGTON, March 2, 2020 /PRNewswire/ -- Evolent Health, Inc. (NYSE: EVH), a health care company that delivers proven clinical and administrative solutions to payers and providers, today announced several significant achievements in 2019, spanning industry recognition, new agreements and clinical and finan

GERMANTOWN, Md., March 2, 2020 /PRNewswire/ -- Precigen, Inc. (Nasdaq: PGEN), a biopharmaceutical company specializing in the development of innovative gene and cell therapies to improve t

SOUTH PLAINFIELD, N.J., March 2, 2020 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today announced a corporate update and reported financial results for the fourth quarter and full year ending December 31, 2019. "2019 was a year of outstanding execution for PTC. I'm proud of the progress made in every area of the business," s

HOUSTON, March 2, 2020 /PRNewswire/ -- Soliton, Inc., (Nasdaq: SOLY) ("Soliton" or the "Company"), a medical device company with a novel and proprietary platform technology licensed from The University of Texas on behalf of the MD Anderson Cancer Center ("MD Anderson"), today reported financial results for the fourth quarter and full year ende

NEW YORK, March 2, 2020 /PRNewswire/ -- The continued worldwide spread of COVID-19 (the coronavirus disease) may weaken the U.S. dollar over the long run by impelling multinational corporates and foreign investors in the United States to repatriate money back to their home countries, said Kuniyuki Hirai

NEW YORK, March 2, 2020 /PRNewswire/ -- Marking its one-year anniversary, New York trial boutique Mukasey Frenchman & Sklaroff LLP